Devendra K Agrawal Selected Research

flt3 ligand protein (flt3 ligand)

11/2010	Fms-like tyrosine kinase 3 ligand decreases T helper type 17 cells and suppressors of cytokine signaling proteins in the lung of house dust mite-sensitized and -challenged mice.
3/2010	Flt3-L increases CD4+CD25+Foxp3+ICOS+ cells in the lungs of cockroach-sensitized and -challenged mice.
12/2009	Fms-like tyrosine kinase 3 ligand regulates migratory pattern and antigen uptake of lung dendritic cell subsets in a murine model of allergic airway inflammation.
4/2009	Fms-like tyrosine kinase 3 ligand increases a lung DC subset with regulatory properties in allergic airway inflammation.
8/2007	Flt3 ligand generates morphologically distinct semimature dendritic cells in ovalbumin-sensitized mice.
2/2005	Treatment with Flt3 ligand plasmid reverses allergic airway inflammation in ovalbumin-sensitized and -challenged mice.
4/2004	Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Devendra K Agrawal Research Topics

Disease

64	Inflammation (Inflammations) 10/2022 - 03/2002
27	Asthma (Bronchial Asthma) 05/2017 - 01/2004
25	Neoplasms (Cancer) 08/2021 - 04/2005
21	Atherosclerosis 10/2022 - 08/2005
20	Hyperplasia 05/2021 - 12/2006
14	Respiratory Hypersensitivity 08/2012 - 03/2002
13	Atherosclerotic Plaque (Atheroma) 01/2022 - 09/2005
11	Carotid Stenosis (Carotid Artery Stenosis) 09/2016 - 07/2003
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2007
9	Vitamin D Deficiency 10/2021 - 08/2012
9	Insulin Resistance 01/2021 - 02/2014
8	Hypoxia (Hypoxemia) 04/2022 - 01/2016
8	Airway Remodeling 02/2016 - 01/2006
6	Adenocarcinoma 08/2021 - 08/2012
6	Tendinopathy (Tendonitis) 02/2021 - 01/2016
6	Obesity 03/2019 - 05/2013
6	Melanoma (Melanoma, Malignant) 01/2017 - 01/2014
5	Thrombosis (Thrombus) 07/2022 - 12/2019
5	Rupture 07/2022 - 10/2004
5	Infections 03/2022 - 01/2014
5	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 01/2017
5	Carcinogenesis 01/2017 - 07/2007
5	Hypersensitivity (Allergy) 08/2010 - 03/2002
4	Myocardial Infarction 07/2022 - 01/2018
4	Incisional Hernia 09/2021 - 01/2019
4	Arthritis (Polyarthritis) 04/2019 - 01/2016
4	Pain (Aches) 01/2018 - 12/2015
4	Leukemia 01/2018 - 10/2010
4	Fibrosis (Cirrhosis) 01/2017 - 01/2007
3	Ischemia 04/2022 - 01/2022
3	Hypertrophy 01/2022 - 07/2007
3	Osteoarthritis 01/2022 - 06/2017
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 08/2015
3	Pathologic Constriction (Stenosis) 02/2016 - 01/2003
3	Hypertension (High Blood Pressure) 01/2016 - 05/2004
3	Lymphoma (Lymphomas) 10/2011 - 10/2010
2	Cicatrix (Scar) 07/2022 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2022 - 08/2010
2	Arteriovenous Fistula 04/2022 - 02/2022
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2022 - 02/2022
2	Diabetic Foot 04/2022 - 02/2022
2	Ulcer 04/2022 - 02/2022
2	COVID-19 03/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

35	CytokinesIBA 10/2022 - 02/2005
29	Vitamin D FDA LinkGeneric 10/2021 - 08/2012
23	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2006
12	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2014
11	HMGB1 Protein (HMG1)IBA 11/2020 - 01/2016
9	AntigensIBA 09/2022 - 03/2002
9	CollagenIBA 01/2022 - 02/2014
9	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 02/2014
8	MicroRNAs (MicroRNA)IBA 04/2022 - 04/2015
8	Receptor for Advanced Glycation End ProductsIBA 11/2021 - 01/2016
7	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2019 - 08/2012
7	OvalbuminIBA 01/2017 - 03/2002
7	flt3 ligand protein (flt3 ligand)IBA 11/2010 - 04/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2006
6	Messenger RNA (mRNA)IBA 01/2017 - 02/2007
6	AllergensIBA 01/2017 - 03/2002
5	LipidsIBA 10/2022 - 10/2004
5	Triggering Receptor Expressed on Myeloid Cells-1IBA 10/2022 - 01/2016
5	oxidized low density lipoproteinIBA 09/2022 - 10/2018
5	Biological ProductsIBA 01/2022 - 12/2014
5	Pharmaceutical PreparationsIBA 03/2019 - 01/2006
5	Insulin-Like Growth Factor I (IGF-1)IBA 09/2015 - 10/2006
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2015 - 08/2005
4	Transcription Factors (Transcription Factor)IBA 04/2022 - 03/2010
4	RNA (Ribonucleic Acid)IBA 02/2022 - 08/2018
4	InflammasomesIBA 04/2021 - 11/2018
4	Insulin (Novolin)FDA Link 01/2021 - 10/2006
4	Histones (Histone)IBA 01/2019 - 08/2015
4	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2016 - 02/2014
4	Angiotensin IIIBA 01/2016 - 04/2005
4	Calcitriol (Calcijex)FDA LinkGeneric 11/2015 - 10/2012
4	Interleukin-10 (Interleukin 10)IBA 02/2015 - 01/2007
4	Methacholine Chloride (Methacholine)FDA Link 08/2009 - 03/2002
3	EnzymesIBA 10/2022 - 05/2004
3	S100A12 ProteinIBA 09/2022 - 10/2017
3	Interleukin-33IBA 01/2022 - 08/2021
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 11/2010
3	AcidsIBA 08/2021 - 10/2017
3	Interleukin-18 (Interleukin 18)IBA 04/2021 - 01/2020
3	CholesterolIBA 01/2020 - 11/2015
3	Insulin-Like PeptidesIBA 01/2019 - 01/2007
3	Immunologic Factors (Immunomodulators)IBA 01/2018 - 08/2009
3	AlarminsIBA 10/2017 - 01/2017
3	Analgesics (Analgesic Drugs)IBA 10/2016 - 11/2014
3	Epidermal Growth Factor (EGF)IBA 09/2015 - 10/2011
3	Interleukin-5 (Interleukin 5)IBA 03/2010 - 03/2002
3	Transforming Growth Factor beta (TGF-beta)IBA 08/2009 - 07/2007
2	LipopolysaccharidesIBA 09/2022 - 10/2017

Therapy/Procedure

27	Therapeutics 09/2022 - 02/2005
9	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2022 - 04/2006
7	Immunomodulation 10/2021 - 04/2004
7	Immunotherapy 01/2018 - 03/2005
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
5	Stents 08/2021 - 12/2006
4	Carotid Endarterectomy 02/2014 - 01/2003
3	Renal Dialysis (Hemodialysis) 04/2022 - 01/2021
3	Laparotomy 01/2021 - 01/2019